Cover Image

The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis

A. Fassio, L. Idolazzi, M.A. Jaber, C. Dartizio, O. Viapiana, M. Rossini, D. Gatti
  • A. Fassio
    Rheumatology Connected Operative Unit, University of Verona, Verona, Italy | angelo.fassio@yahoo.it
  • L. Idolazzi
    Rheumatology Connected Operative Unit, University of Verona, Verona, Italy
  • M.A. Jaber
    Rheumatology Connected Operative Unit, University of Verona, Verona, Italy
  • C. Dartizio
    Rheumatology Connected Operative Unit, University of Verona, Verona, Italy
  • O. Viapiana
    Rheumatology Connected Operative Unit, University of Verona, Verona, Italy
  • M. Rossini
    Rheumatology Connected Operative Unit, University of Verona, Verona, Italy
  • D. Gatti
    Rheumatology Connected Operative Unit, University of Verona, Verona, Italy

Abstract

Osteoporosis is a well-known extra-articular complication in rheumatoid arthritis (RA). The chronic corticosteroid treatment, the functional impairment associated with RA and the disease itself appear to be the most relevant determinants. Most of the previous studies involved postmenopausal women, in whom the estrogenic deficiency might amplify the negative effect towards bone of both RA and corticosteroid therapy. We decided to evaluate bone health in a cohort of premenopausal RA patients. The study population includes 47 premenopausal women attending our outpatient clinic for RA and twice as many healthy age-matched control women selected from the hospital personnel. The bone density at the spine and femoral neck were significantly lower in patients with RA as compared with controls. When spine bone mineral density (BMD) values were adjusted for the cumulative glucocorticoid (GC) dose alone and for the cumulative GC dose plus body mass index (BMI) the mean differences between two groups decreased but they remained statistically significant. We found no difference when the spine BMD was adjusted for cumulative GC dose, BMI and health assessment questionnaire. The difference in femoral neck BMD remained statistically significant also after all the same adjustments. In conclusion, our study shows that a BMD deficiency is frequent also in premenopausal women affected by RA, especially at femoral site and that the main determinants of this bone loss are not only the disease-related weight loss, corticosteroid therapy and functional impairment, but also the systemic effects of the disease itself.

Keywords

Rheumatoid arthritis; glucocorticoid therapy; premenopausal women.

Full Text:

PDF
Submitted: 2016-03-14 16:50:47
Published: 2016-09-09 10:50:17
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
716

Views:
PDF
344

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 A. Fassio, L. Idolazzi, M.A. Jaber, C. Dartizio, O. Viapiana, M. Rossini, D. Gatti

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185     •     Privacy